News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Commencement of Immunotherapy Dosing for Leukemia Patients in Phase I/II Trial of ProTcell Therapy SMART101 in ReSET-02
Thursday, September 28, 2023Smart Immune a clinicalstage biotechnology company focusing on the development of ProTcell a Tcell progenitor therapy platform designed to swiftly rejuvenate the immune system has officially initiated its ReSET Phase III trial for adult acute leukemi...
FDA Approves Chrysalis for Clinical Trials of Chrysalin™ (TP508)
Wednesday, September 27, 2023Chrysalis BioTherapeutics Inc made an announcement today regarding the approval from the US Food and Drug Administration FDA to commence human clinical trials aimed at treating acute lung failure
Novo Nordisk and Evotec Collaborate to Introduce LAB eN², a Translational Drug Discovery Accelerator Targeting Innovation Gaps in Cardiometabolic Diseases
Wednesday, September 27, 2023Novo Nordisk and Evotec SE have introduced LAB eN a novel program designed to accelerate earlystage research originating from academic institutions with a primary focus on addressing unmet needs in cardiometabolic diseases rare blood disorders and ra...
Senores Pharmaceuticals, Inc. Introduces Nicardipine Hydrochloride Capsules USP, Available in 20 Mg and 30 Mg, to the U.S. Market.
Tuesday, September 26, 2023Senores Pharmaceuticals Inc has recently introduced Nicardipine Hydrochloride Capsules USP in mg and mg strengths to the US market
Pierre Fabre and Vernalis Laboratories Announce Collaboration in Oncology Drug Research and Development
Tuesday, September 26, 2023Laboratoires Pierre Fabre and Vernalis RD Ltd a whollyowned subsidiary of HitGen Inc are excited to announce a longterm collaboration aimed at the discovery of preclinical candidates for a variety of oncological targets
Glycotope and Max Delbruck Center Form Research Collaboration to Investigate the Fusion of Glycotargets and Car Technology
Monday, September 25, 2023Glycotope GmbH Glycotope and the Max Delbrck Center for Molecular Medicine in the Helmholtz Association have forged a collaborative agreement to investigate the potential synergy between Glycotopes antibodies targeting proteincarbohydrate combined gl...
Jazz Pharmaceuticals Granted European Commission Authorization for Enrylaze® in Treating Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Friday, September 22, 2023Jazz Pharmaceuticals plc Nasdaq JAZZ has recently obtained marketing authorization from the European Commission EC for Enrylaze JZP a recombinant Erwinia asparaginase or crisantaspase
Gilgamesh Pharmaceuticals Achieves Success in Phase 1 SAD/MAD Clinical Trials for GM-1020
Friday, September 22, 2023Gilgamesh Pharma is delighted to announce the successful completion of its Phase Single Ascending Dose SAD and Multiple Ascending Dose MAD trials for GM a novel oral smallmolecule NMDA receptor channel blocker currently undergoing clinical developme...
Revolo Biotherapeutics Completes Phase 1 Multiple Ascending Dose Clinical Trial of '1104
Friday, September 22, 2023Revolo Biotherapeutics a company dedicated to developing therapies aimed at resetting the immune system for achieving longterm remission in patients with autoimmune and allergic diseases
SpyBiotech Submits Clinical Trial Application to MHRA for SPYVLP01
Thursday, September 21, 2023SpyBiotech a biotechnology company known for its groundbreaking vaccine platform technology effective against infectious diseases cancer and chronic conditions has announced the submission of a Clinical Trial Application CTA to the UKs Medicines and...
